ICON PLC (ICLR) director reports RSU vesting, new grant and tax sell-to-cover sales
Rhea-AI Filing Summary
ICON PLC director Eugene Pacelli McCague reported multiple equity transactions. On August 10, 2026, 1,732 restricted share units granted on May 22, 2025 vested, converting into 1,732 ordinary shares with a nominal conversion price equal to the EUR 0.06 par value per share deducted from pay. On the same date he received a new grant of 1,324 restricted share units scheduled to vest on May 22, 2027.
On August 11, 2026, he sold an aggregate of 841 ordinary shares in several tranches at weighted-average prices between $162.08 and $166.1599 per share. According to the footnotes, these sales were solely to cover tax withholding obligations via a “sell to cover” arrangement and did not represent discretionary trading decisions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares F3, F4 | 88 | $162.72 | $14K |
| Sale | Ordinary Shares F3, F5 | 96 | $163.77 | $16K |
| Sale | Ordinary Shares F3, F6 | 590 | $164.47 | $97K |
| Sale | Ordinary Shares F3, F7 | 67 | $165.51 | $11K |
| Exercise | Restricted Share Units F2, F1 | 1,732 | $0.00 | $0.00 |
| Grant/Award | Restricted Share Units F2, F8 | 1,324 | $0.00 | $0.00 |
| Exercise | Ordinary Shares F1, F2 | 1,732 | -- | -- |
Footnotes (8)
- F1. These restricted share units were granted on May 22, 2025 and vested on August 10, 2026.
- F2. Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting.
- F3. The sale reported represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $162.08 to $163.0799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $163.15 to $164.1499, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
- F6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $164.16 to $165.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
- F7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple aggregated transactions at prices within the range of $165.16 to $166.1599, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
- F8. These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027.
Key Figures
Key Terms
sell to cover financial
foreign private issuer regulatory
weighted average price financial
AI-generated analysis. How Rhea-AI works. Not financial advice.